lucidumol A
Identification
| Name | lucidumol A |
| CAS Number | 217476-73-8 |
| FDA UNII | Search |
| Molecular Formula | C30 H48 O4 |
| Molecular Weight | 472.70936000 |
| Nikkaji Number | J1.005.775B |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 0.002133 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for lucidumol A usage levels up to | not for fragrance use. |
| Recommendation for lucidumol A flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
(5R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-
dihydroxy-6-methylheptan-2-yl]-4,4,10,13,14-pentamethyl-2,5,6,11,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,7-dione
lanost-8-ene-3,7-dione, 24,25-dihydroxy-, (24S)-
PubMed:
Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase.
PubMed:
Distinct Responses of Cytotoxic Ganoderma lucidum Triterpenoids in Human Carcinoma Cells.
PubMed:
Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum.
PubMed:
Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease.